United States· US:69367-340_2226fb84-50af-45b1-8a9f-72984e331519
Carbidopa and Levodopa
A dopa and dopa derivatives product containing carbidopa and levodopa, registered in United States by Westminster Pharmaceuticals, LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Carbidopa and levodopa is registered in 3 of 19 countries.
Countries holding a registration under ATC N04BA (dopa and dopa derivatives), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Carbidopa and levodopa · ATC N04BA
3 / 19 countries
- Ireland
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Carbidopa and Levodopa
- Manufacturer
- Westminster Pharmaceuticals, LLC
- Country
- United States (US)
- ATC code
- N04BA
- ATC class
- Dopa and dopa derivatives
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 2
- ndc116936734001100 TABLET in 1 BOTTLE, PLASTIC (69367-340-01)
- ndc116936734005500 TABLET in 1 BOTTLE, PLASTIC (69367-340-05)
Regulatory notes
Same class
Other records under N04BA
Dopa and dopa derivatives, as other registers publish it.
- United StatesCarbidopa and LevodopaMajor Pharmaceuticals
- United StatesCarbidopa and LevodopaWestminster Pharmaceuticals, LLC
- United StatesCarbidopa and LevodopaWestminster Pharmaceuticals, LLC
- United StatesCarbidopa and LevodopaMajor Pharmaceuticals
- United StatesCarbidopa and LevodopaScieGen Pharmaceuticals Inc
- United StatesCarbidopa and LevodopaScieGen Pharmaceuticals Inc
- United StatesCARBIDOPA AND LEVODOPASun Pharmaceutical Industries, Inc.
- United StatesCARBIDOPA AND LEVODOPASun Pharmaceutical Industries, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b80fb9ff-ac83-4c52-aacd-ed8246e4c567 GET /v1/drugs/b80fb9ff-ac83-4c52-aacd-ed8246e4c567?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"spl_meta": {
"87ab55c9-203d-d595-3e3e-0e38f2f6d9c4": {
"match": "brand_token",
"title": "CARBIDOPA AND LEVODOPA TABLET [DR. REDDY'S LABORATORIES INC]",
"spl_version": "4",
"published_date": "2026-05-21"
}
},
"productid": "69367-340_2226fb84-50af-45b1-8a9f-72984e331519",
"productndc": "69367-340",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "214092",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "10MG;100MG",
"product_no": "001",
"approval_date": "May 7, 2021"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "25MG;100MG",
"product_no": "002",
"approval_date": "May 7, 2021"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "25MG;250MG",
"product_no": "003",
"approval_date": "May 7, 2021"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CARBIDOPA; LEVODOPA",
"proprietary_name": "Carbidopa and Levodopa",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA214092",
"marketing_category": "ANDA",
"nonproprietary_name": "Carbidopa and Levodopa",
"start_marketing_date": "20210930",
"active_numerator_strength": "25; 250"
}See everything about carbidopa and levodopa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.